Articles

Menopausal hormone therapy has changed a great deal since the study that called it into question two decades ago. Today the conversation is about estradiol and micronised progesterone, the window of opportunity and tailored dosing. Here's what the evidence says, without scaremongering and without overselling.

Obstructive sleep apnoea is a common disorder in which breathing is reduced or stops during the night. Here is what causes it, how it is diagnosed and which treatment options the evidence supports today.

Both are PDE5 inhibitors and both need sexual stimulation to work. What differs is how long they stay in the body, how food affects them, which dosing regimens are approved in Spain and the extra indication one of them has. Here are the real differences, based on the AEMPS product information and the 2025 European urology guideline.

Tadalafil is a PDE5 inhibitor authorised in Spain for erectile dysfunction and for the symptoms of benign prostatic hyperplasia. We explain how it works, what the guidelines say, which myths don't hold up and what it must never be combined with.

Ashwagandha is the star plant on the supplement shelves: it promises calm, less stress and better sleep. The evidence shows a small effect on anxiety and cortisol, while several European agencies have raised red flags over the liver and the thyroid. Here is what is known, what is not, and where it stands from a regulatory point of view in Spain.

Low-dose aspirin is a medicine cabinet classic, but the science has gradually refined when it genuinely protects you and when the bleeding risk eats up the benefit. Here's what the trials and guidelines say, without the scaremongering.

Phytoestrogens, isoflavones, vitamins, omega-3… the menopause supplement shelf is enormous, but the evidence is more modest than the packaging suggests. Here's what the science says, what the law allows a label to claim, and why a food supplement is never a medicine.

You notice more hair than usual on the pillow or in the shower and it gives you a fright. Telogen effluvium is the most common cause of diffuse hair loss: it appears after physical stress, childbirth or a hormonal change, and in most cases it resolves on its own. Here is why it happens, what the evidence says and what is actually known.

Metabolic syndrome is not a single disease but a cluster of risk factors that tend to travel together: waist, blood sugar, blood pressure and blood fats. Here is what the evidence says, how common it is in Spain and what genuinely works to lower the risk.

Testosterone boosters, maca, tribulus, zinc, ashwagandha… the shelves are full of promises. We take a calm look at what the science actually supports, what is pure marketing and why it matters to tell a genuine deficiency apart from a passing trend.

Survodutide is an investigational drug that activates two receptors at once: the GLP-1 receptor and the glucagon receptor. It is in advanced trials for obesity and for liver disease, but it is not yet authorised in Spain. Here is what the data actually show.

We explain how a telemedicine service for menopause works in Spain and what the law requires of any health website offering consultations: authorisation of the clinic, transparency and clear limits on advertising prescription-only medicines.
Online medical assessment, prescription when appropriate and 1:1 follow-up with this team.